Brii Biosciences

Pharma

Roche-Innovent, AstraZeneca, Viatris and more—Fierce Pharma Asia

Roche and Ideaya separately licensed ADCs from Chinese firms. Experts weighed in on AZ's China probes. A Viatris plant got a warning letter. And more.

Angus Liu Jan 3, 2025 8:37am

Big Pharma CEOs in China, AstraZeneca, WuXi—Fierce Pharma Asia

Mar 29, 2024 10:10am

Takeda, WuXi, LianBio—Fierce Pharma Asia

Feb 16, 2024 8:24am

pay deal hand over cash licensing transaction money

VBI Vaccines shrinks 'long-term burn' with $33M Brii Bio deal

Feb 14, 2024 11:12am

AZ-Daiichi, Moderna, Takeda and more—Fierce Pharma Asia

Jul 7, 2023 9:45am

Takeda, Eisai, GSK and more—Fierce Pharma Asia

Mar 31, 2023 8:27am